Identification of up- and down-regulated proteins in gemcitabine-resistant pancreatic cancer cells using two-dimensional gel electrophoresis and mass spectrometry

Yasuhiro Kuramitsu, Kumiko Taba, Shomei Ryozawa, Kanako Yoshida, Xiulian Zhang, Toshiyuki Tanaka, Shin Ichiro Maehara, Yoshihiro Maehara, Isao Sakaida, Kazuyuki Nakamura

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

The prognosis of patients with pancreatic cancer is very poor because of late diagnosis and the lack of response to various therapies. Pancreatic cancer is generally resistant to chemotherapy and is highly fatal. Gemcitabine (GEM) appears to be the only effective agent for treatment of pancreatic cancer. However, a high level of inherent and acquired tumor resistance makes the clinical impact of GEM modest. Proteomic differential display analysis for GEM-sensitive human pancreatic adenocarcinoma cell line KLM1 and GEM-resistant KLMl-R cells by using two-dimensional gel electrophoresis and liquid chromatography tandem mass spectrometry produced 33 protein spots. Of these, 23 were up-regulated and 10 were down-regulated in KLM1-R compared to KLM1 cells. The up-regulated proteins include acidic leucine-rich nuclear phosphoprotein 32 family member A, reticulocalbin-1, gamma-synuclein, microtubule-associated protein RPIEB family, sialic acid synthase, peptidyl-prolyl cis-trans isomerase A, far upstream element-binding protein 2 and catalase. The down-regulated proteins include far upstream element-binding protein 1, gamma-synuclein, galectin-1 and stathmin. Two spots of heat-shock protein 27 were up-regulated in KLM1-R cells. These results suggest an important complementary role for proteomics in the identification of proteins which may play a role in the poor response of pancreatic cancer to GEM.

Original languageEnglish
Pages (from-to)3367-3372
Number of pages6
JournalAnticancer research
Volume30
Issue number9
Publication statusPublished - Sep 2010

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Identification of up- and down-regulated proteins in gemcitabine-resistant pancreatic cancer cells using two-dimensional gel electrophoresis and mass spectrometry'. Together they form a unique fingerprint.

  • Cite this

    Kuramitsu, Y., Taba, K., Ryozawa, S., Yoshida, K., Zhang, X., Tanaka, T., Maehara, S. I., Maehara, Y., Sakaida, I., & Nakamura, K. (2010). Identification of up- and down-regulated proteins in gemcitabine-resistant pancreatic cancer cells using two-dimensional gel electrophoresis and mass spectrometry. Anticancer research, 30(9), 3367-3372.